← Return to Anyone on Pluvicto (Lu 177), a new drug for prostate cancer?
DiscussionAnyone on Pluvicto (Lu 177), a new drug for prostate cancer?
Prostate Cancer | Last Active: Sep 14 7:33am | Replies (188)Comment receiving replies
Replies to "Thanks, I saw that. I appreciate the reminder. I understand darolutimide is very similar to enzalutimide..."
My first gene mutation results showed that I do not respond to any of the newer immunotherapy drugs. I wish I had known that before being on abiraterone for 8 months. Waiting now for my second results from a recent prostate biopsy to see if any other mutations are present while I wait for Pluvitco. All we can do is remain hopeful and definitely place our faith in the research being performed. Science is definitely amazing.